Dermatol. praxi. 2026;20(1):30-32 | DOI: 10.36290/der.2026.005

Morbus Favre-Racouchot successfully treated with a topical retinoid and manual expression: a case report

MUDr. Barbara Pásztorová, MUDr. Zuzana Nevoralová
Kožní oddělení, Nemocnice Jihlava, p. o.

Morbus Favre-Racouchot (MFR), also known as nodular elastosis, is a chronic skin disease caused by long-term exposure to sunlight. It is characterized by the presence of comedones and cysts. This article presents a case report of a 62-year-old patient with extensive facial macrocomedones lasting for more than 40 years. Long-term treatment with topical adapalene and manual expression led to a reduction of skin lesions by more than 90%. This case demonstrates that above mentioned treatment can be very effective.

Keywords: Morbus Favre-Racouchot, nodular elastosis, sun damage, macrocomedones, topical retinoids, adapalene.

Accepted: March 4, 2026; Published: April 8, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pásztorová B, Nevoralová Z. Morbus Favre-Racouchot successfully treated with a topical retinoid and manual expression: a case report. Dermatol. praxi. 2026;20(1):30-32. doi: 10.36290/der.2026.005.
Download citation

References

  1. Nayak VT, Konda D. Favre-Racouchot syndrome. J Skin Sex Transm Dis. 2023;5:62-63. Go to original source...
  2. Hasan Z, Kothottil R, Adinarayan M. A clinicopathologic case report of Favre-Racouchot syndrome with review of literature. Int J Health Sci Res. 2016; 6(10):296-298.
  3. Sonthalia S, Arora R, Chhabra N, et al. FavreRacouchot syndrome. Indian Dermatol Online J. 2014;5:1 Go to original source... Go to PubMed...
  4. Patterson WM, Fox MD, Schwartz RA. Favre Racouchot disease: review. Int J Dermatol. 2004;43(3):167-169. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.